fenoterol Î² adrenoreceptor agonist classed sympathomimetic agonist inhaled bronchodilator asthma medication fenoterol produced sold boehringer ingelheim berotec n combination ipratropium berodual n patented came medical use concerns emerged safety use associated increased risk death see fenoterol shortacting agonist also stimulates receptors fenoterol cardiovascular toxicity isoprenaline fenoterol widely used new zealand late removed new zealand drug tariff introduction widespread use associated epidemic asthma series casecontrol studies demonstrated asthmatics using fenoterol likely die asthma compared controls treated alternative beta agonists risk asthma deaths particularly high severe mortality rate declined following withdrawal fenoterol without evidence supporting alternative explanation abrupt rise fall asthma data support confounding severity explanation excess alternative shortacting beta agonists associated increased mortality eg salbutamol molecule two different stereogenic centers thus four stereoisomers may exist rr rs sr ssstereoisomers see figure fenoterol racemate rr ssenantiomers racemate times effective compared racemate rs httpsenwikipediaorgwikifenoterol